Denis Chem Lab Ltd
BSE:537536
Denis Chem Lab Ltd
Denis Chem Lab Ltd. engages in the manufacture and sale of transfusion solution in bottles. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2014-02-21. The firm is engaged in the business of manufacturing pharmaceutical transfusion solution in bottles. The company offers a range of sterile intravenous injectables for human and veterinary consumption. Its product offerings include carbohydrate solutions, carbohydrate in sodium chloride solutions, sodium chloride solutions, potassium chloride solutions, sodium lactate/ Ringer's solution, multi electrolyte solutions, dialysis solutions, mannitol solutions, irrigation solutions, plasma volume expanders, amino acids, antibiotic solutions and other miscellaneous products. The company manufactures sterile intravenous injectables in filled volumes ranging from 100 milliliters to 10 liters. In addition to manufacturing its own products, it sells under its own brands. The firm also uses its facility to manufacture products on a contract basis for third parties, including certain multinational pharmaceutical companies.
Denis Chem Lab Ltd. engages in the manufacture and sale of transfusion solution in bottles. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2014-02-21. The firm is engaged in the business of manufacturing pharmaceutical transfusion solution in bottles. The company offers a range of sterile intravenous injectables for human and veterinary consumption. Its product offerings include carbohydrate solutions, carbohydrate in sodium chloride solutions, sodium chloride solutions, potassium chloride solutions, sodium lactate/ Ringer's solution, multi electrolyte solutions, dialysis solutions, mannitol solutions, irrigation solutions, plasma volume expanders, amino acids, antibiotic solutions and other miscellaneous products. The company manufactures sterile intravenous injectables in filled volumes ranging from 100 milliliters to 10 liters. In addition to manufacturing its own products, it sells under its own brands. The firm also uses its facility to manufacture products on a contract basis for third parties, including certain multinational pharmaceutical companies.
